Literature DB >> 15389728

Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation.

Jindrich Cinatl1, Martin Scholz, Hans Wilhelm Doerr.   

Abstract

It has been known for a long time that cytomegalovirus (CMV) has evolved mechanisms that allow the escape from the host immune surveillance. In the past, many efforts have been done to elucidate the molecular mechanisms underlying this virus-mediated immune escape and thus virus persistence. However, it is unknown, whether CMV may also impair immune responses directed against tumor cells. This might have severe consequences on tumor progression and may explain the growing evidence for CMV-mediated oncomodulation. This review summarizes recent work on CMV-mediated immune escape mechanisms of tumor cells and oncomodulation and proposes novel aspects that may be important for understanding the CMV-associated tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389728     DOI: 10.1002/med.20018

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  11 in total

1.  Lack of association of herpesviruses with brain tumors.

Authors:  S Poltermann; B Schlehofer; K Steindorf; P Schnitzler; K Geletneky; J R Schlehofer
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

2.  Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.

Authors:  Rachel B Gill; Scott H James; Mark N Prichard
Journal:  J Gen Virol       Date:  2012-05-02       Impact factor: 3.891

3.  Absence of human cytomegalovirus infection in childhood brain tumors.

Authors:  Iacopo Sardi; Maurizio Lucchesi; Sabrina Becciani; Ludovica Facchini; Milena Guidi; Anna Maria Buccoliero; Maria Moriondo; Gianna Baroni; Alessia Stival; Silvia Farina; Lorenzo Genitori; Maurizio de Martino
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

Review 4.  Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.

Authors:  Martin Michaelis; Peter Baumgarten; Michel Mittelbronn; Pablo Hernáiz Driever; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2010-10-22       Impact factor: 3.402

5.  Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed?

Authors:  Paul R Lübeck; Hans Wilhelm Doerr; Holger F Rabenau
Journal:  Med Microbiol Immunol       Date:  2009-12-01       Impact factor: 3.402

Review 6.  The story of human cytomegalovirus and cancer: increasing evidence and open questions.

Authors:  Martin Michaelis; Hans W Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

7.  Upregulation of Toll-like receptor 2 expression in colorectal cancer infected by human cytomegalovirus.

Authors:  Xutong Li; Dongmeng Qian; Fang Ju; Bin Wang
Journal:  Oncol Lett       Date:  2014-10-15       Impact factor: 2.967

8.  Cytomegalovirus infection in malignant pleural mesothelioma.

Authors:  DeVon Hunter-Schlichting; Karl T Kelsey; Ryan Demmer; Manish Patel; Raphael Bueno; Brock Christensen; Naomi Fujioka; Deepa Kolarseri; Heather H Nelson
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

9.  Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus.

Authors:  Ren Qi; Zeng Hua-Song; Zeng Xiao-Feng
Journal:  Eur J Med Res       Date:  2013-02-01       Impact factor: 2.175

Review 10.  Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.

Authors:  Ranim El Baba; Georges Herbein
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.